Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Sees Significant Decrease in Short Interest

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) saw a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 774,400 shares, a drop of 13.7% from the February 28th total of 897,700 shares. Based on an average daily volume of 1,100,000 shares, the short-interest ratio is currently 0.7 days. Approximately 3.7% of the company’s shares are sold short.

Ekso Bionics Price Performance

NASDAQ EKSO traded up $0.01 on Thursday, reaching $0.42. 42,399 shares of the stock traded hands, compared to its average volume of 345,483. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. The company has a market cap of $10.45 million, a price-to-earnings ratio of -0.65 and a beta of 1.33. The firm’s fifty day simple moving average is $0.51 and its 200 day simple moving average is $0.72. Ekso Bionics has a 12 month low of $0.34 and a 12 month high of $1.53.

Ekso Bionics (NASDAQ:EKSO) last announced its earnings results on Monday, March 3rd. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.07). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The firm had revenue of $5.09 million during the quarter, compared to analyst estimates of $5.05 million. As a group, research analysts predict that Ekso Bionics will post -0.48 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on EKSO shares. HC Wainwright reissued a “buy” rating and issued a $9.00 price objective on shares of Ekso Bionics in a research report on Tuesday, March 4th. StockNews.com started coverage on Ekso Bionics in a research report on Thursday, March 27th. They issued a “hold” rating on the stock. Finally, Lake Street Capital reduced their price target on shares of Ekso Bionics from $2.00 to $1.00 and set a “buy” rating on the stock in a research report on Tuesday, March 4th.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.